InVivo adds 1st UK clinical site for INSPIRE study: 5 things to know

InVivo Therapeutics added the first INSPIRE study clinical site in the United Kingdom.

Advertisement

Here are five things to know:

 

1. Middlesbrough, U.K.-based James Cook University Hospital is the 33rd INSPIRE clinical site.

 

2. James Cook University Hospital’s Golden Jubilee Regional Spinal Cord Injuries Centre solely treats spinal cord injuries.

 

3. Dr. Manjunath Prasad serves as the site’s principal investigator.

 

4. The INSPIRE study tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.

 

5. InVivo has enrolled sites in the U.S., Canada and the U.K.

 

More articles on devices:
Orthopedic trauma devices market projects 7.2% CAGR: 6 takeaways
Providence Medical Technology reports outcomes from 2 studies on DTRAX Expandable Cage: 5 notes
InVivo Therapeutics welcomes Dr. Richard Toselli as CMO: 4 highlights

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.